Agammaglobulinemia is a rare genetic disorder characterized by the absence or extremely low levels of immunoglobulins, leading to a weakened immune system. The ICD-10 code for Agammaglobulinemia is D80.0. In the previous ICD-9 coding system, the corresponding code was 279.04. It is important to consult with a healthcare professional for accurate diagnosis and appropriate treatment of this condition.
Agammaglobulinemia, also known as common variable immunodeficiency (CVID), is a rare primary immunodeficiency disorder characterized by the absence or extremely low levels of immunoglobulins (antibodies) in the blood. This condition impairs the immune system's ability to fight off infections, making affected individuals more susceptible to recurrent bacterial respiratory tract infections, gastrointestinal infections, and other opportunistic infections.
In the International Classification of Diseases, Tenth Revision (ICD-10), the specific code for Agammaglobulinemia is D80.0. This code falls under the "Other immunodeficiencies" category (D80-D89) and is further classified as a "Combined immunodeficiency disorders" subcategory (D80). It is important to note that CVID encompasses a heterogeneous group of disorders, and the ICD-10 code D80.0 is specifically assigned to Agammaglobulinemia.
As for the ICD-9 code, which was used prior to the implementation of ICD-10, the corresponding code for Agammaglobulinemia is 279.04. In the ninth revision, this condition was categorized under "Defects in the immune system" (279) and further classified as "Combined immunity deficiency" (279.0).
It is crucial to consult a healthcare professional or refer to the official coding guidelines for accurate and up-to-date information regarding ICD codes, as they may vary based on the individual's specific condition and associated factors.